Novel Oral Anticoagulation Laboratory Monitoring, Interaction and Treatment of Complications

Author(s): Aydin Huseynov, Stefan Baumann, Ibrahim El-Battrawy, Ibrahim Akin.

Journal Name: Cardiovascular & Hematological Disorders-Drug Targets

Volume 15 , Issue 2 , 2015

Become EABM
Become Reviewer

Graphical Abstract:


The use of novel oral anticoagulation (NOACs) has emerged as an alternative for oral anticoagulation with vitamin-K antagonists in different clinical settings. However, despite the several advantages of these new drugs, there are also several limitations and cautious is recommended in different clinical settings in patients with a high comorbidity index. This review article will describe the current evidence of treatment monitoring, possible drug interaction, and will give an overview about treatment options in case of complications.

Keywords: Coumadin, novel oral anticoagulation, thrombembolism, warfarin.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Page: [115 - 119]
Pages: 5
DOI: 10.2174/1871529X1502151209112437

Article Metrics

PDF: 48